Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Drug-Vaccine Interaction Study to Examine Whether Co-administering AV7909 With Ciprofloxacin or Doxycycline Affects Antibiotic Pharmacokinetics or AV7909 Immunogenicity in Healthy Adults

NCT04067011 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT04067011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04067011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Drug-Vaccine Interaction Study to Examine Whether Co-administering AV7909 With Ciprofloxacin or Doxycycline Affects Antibiotic Pharmacokinetics or AV7909 Immunogenicity in Healthy Adults
Lead sponsor
Emergent BioSolutions
Phase
Phase 2
Overall status
Completed
Start date
August 12, 2019
Completion date
March 19, 2020
Enrollment
210 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anthrax